These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25511824)

  • 1. Biosynthesis of a steroid metabolite by an engineered Rhodococcus erythropolis strain expressing a mutant cytochrome P450 BM3 enzyme.
    Venkataraman H; Te Poele EM; Rosłoniec KZ; Vermeulen N; Commandeur JN; van der Geize R; Dijkhuizen L
    Appl Microbiol Biotechnol; 2015 Jun; 99(11):4713-21. PubMed ID: 25511824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
    Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
    Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site substitution A82W improves the regioselectivity of steroid hydroxylation by cytochrome P450 BM3 mutants as rationalized by spin relaxation nuclear magnetic resonance studies.
    Rea V; Kolkman AJ; Vottero E; Stronks EJ; Ampt KA; Honing M; Vermeulen NP; Wijmenga SS; Commandeur JN
    Biochemistry; 2012 Jan; 51(3):750-60. PubMed ID: 22208729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Enzymatic Route to α-Tocopherol Synthons: Aromatic Hydroxylation of Pseudocumene and Mesitylene with P450 BM3.
    Dennig A; Weingartner AM; Kardashliev T; Müller CA; Tassano E; Schürmann M; Ruff AJ; Schwaneberg U
    Chemistry; 2017 Dec; 23(71):17981-17991. PubMed ID: 28990705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydroxylation of diverse flavonoids by CYP450 BM3 variants: biosynthesis of eriodictyol from naringenin in whole cells and its biological activities.
    Chu LL; Pandey RP; Jung N; Jung HJ; Kim EH; Sohng JK
    Microb Cell Fact; 2016 Aug; 15(1):135. PubMed ID: 27495155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined computational and experimental study on selective flucloxacillin hydroxylation by cytochrome P450 BM3 variants.
    Luirink RA; Dekker SJ; Capoferri L; Janssen LFH; Kuiper CL; Ari ME; Vermeulen NPE; Vos JC; Commandeur JNM; Geerke DP
    J Inorg Biochem; 2018 Jul; 184():115-122. PubMed ID: 29723739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of chaperones GroEL/ES from Escherichia coli enhances indigo biotransformation production of cytochrome P450 BM3 mutant.
    Peng S; Chu Z; Lu J; Li D; Wang Y; Yang S; Zhang Y
    Biotechnol Lett; 2023 Aug; 45(8):993-1000. PubMed ID: 37243776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
    de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
    J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of a fluorescence-based continuous-flow bioassay to screen for diversity of cytochrome P450 BM3 mutant libraries.
    Reinen J; Ferman S; Vottero E; Vermeulen NP; Commandeur JN
    J Biomol Screen; 2011 Feb; 16(2):239-50. PubMed ID: 21297109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and heterologous expression of the aurachin RE biosynthesis gene cluster afford a new cytochrome P450 for quinoline N-hydroxylation.
    Kitagawa W; Ozaki T; Nishioka T; Yasutake Y; Hata M; Nishiyama M; Kuzuyama T; Tamura T
    Chembiochem; 2013 Jun; 14(9):1085-93. PubMed ID: 23677853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient screening of cytochrome P450 BM3 mutants for their metabolic activity and diversity toward a wide set of drug-like molecules in chemical space.
    Reinen J; van Leeuwen JS; Li Y; Sun L; Grootenhuis PD; Decker CJ; Saunders J; Vermeulen NP; Commandeur JN
    Drug Metab Dispos; 2011 Sep; 39(9):1568-76. PubMed ID: 21673132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single active site mutation inverts stereoselectivity of 16-hydroxylation of testosterone catalyzed by engineered cytochrome P450 BM3.
    Venkataraman H; Beer SB; Bergen LA; Essen Nv; Geerke DP; Vermeulen NP; Commandeur JN
    Chembiochem; 2012 Mar; 13(4):520-3. PubMed ID: 22275147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First steps towards a Zn/Co(III)sep-driven P450 BM3 reactor.
    Zhao L; Güven G; Li Y; Schwaneberg U
    Appl Microbiol Biotechnol; 2011 Aug; 91(4):989-99. PubMed ID: 21562982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biotransformation of hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) by a rabbit liver cytochrome P450: insight into the mechanism of RDX biodegradation by Rhodococcus sp. strain DN22.
    Bhushan B; Trott S; Spain JC; Halasz A; Paquet L; Hawari J
    Appl Environ Microbiol; 2003 Mar; 69(3):1347-51. PubMed ID: 12620815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regioselective hydroxylation of 17β-estradiol by mutants of CYP102A1 from Bacillus megaterium.
    Cha GS; Ryu SH; Ahn T; Yun CH
    Biotechnol Lett; 2014 Dec; 36(12):2501-6. PubMed ID: 25129047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of cytochrome P450 BM3 mutants as biocatalysts for the profiling of estrogen receptor binding metabolites of the mycotoxin zearalenone.
    Reinen J; Kalma LL; Begheijn S; Heus F; Commandeur JN; Vermeulen NP
    Xenobiotica; 2011 Jan; 41(1):59-70. PubMed ID: 21087115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioconversion of substituted naphthalenes and β-eudesmol with the cytochrome P450 BM3 variant F87V.
    Misawa N; Nodate M; Otomatsu T; Shimizu K; Kaido C; Kikuta M; Ideno A; Ikenaga H; Ogawa J; Shimizu S; Shindo K
    Appl Microbiol Biotechnol; 2011 Apr; 90(1):147-57. PubMed ID: 21184059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a second Rhodococcus erythropolis SQ1 3-ketosteroid 9alpha-hydroxylase activity comprising a terminal oxygenase homologue, KshA2, active with oxygenase-reductase component KshB.
    van der Geize R; Hessels GI; Nienhuis-Kuiper M; Dijkhuizen L
    Appl Environ Microbiol; 2008 Dec; 74(23):7197-203. PubMed ID: 18836008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of a minimal enriched P450 BM3 mutant library for hydroxylation of cyclic and acyclic alkanes.
    Weber E; Seifert A; Antonovici M; Geinitz C; Pleiss J; Urlacher VB
    Chem Commun (Camb); 2011 Jan; 47(3):944-6. PubMed ID: 21079837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A P450 fusion library of heme domains from Rhodococcus jostii RHA1 and its evaluation for the biotransformation of drug molecules.
    Kulig JK; Spandolf C; Hyde R; Ruzzini AC; Eltis LD; Grönberg G; Hayes MA; Grogan G
    Bioorg Med Chem; 2015 Sep; 23(17):5603-9. PubMed ID: 26234905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.